glp 1 research papers Structure-Based Discovery of Orthosteric Non-Peptide GLP-1R Agonists via Integrated Virtual Screening and Molecular Dynamics PDF) White Paper: GLP-1 Receptor

See individual product page for important safety information

GLP-1 drugs can cost several thousand dollars per year

The FDA has issued warnings about the risks associated with compounded semaglutide, noting that some products may use different salt forms of the ingredient (semaglutide sodium and semaglutide acetate), which have not been studied for safety or effectiveness (11)

*Frequency may vary depending on healthcare provider recommendations for individual people

Overall, GLP-1 RAs represent a biologically plausible and clinically relevant approach to bridging metabolic and psychiatric care, with the potential to improve outcomes in patients with mood disorders who carry a high metabolic burden